Leverage of genetic variants proxying smoking intensity to explore the broad health consequences of smoking.
作者信息
Gill Dipender
机构信息
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Centre for Pharmacology and Therapeutics, Department of Medicine, Hammersmith Campus, Imperial College London, London, United Kingdom.
出版信息
EClinicalMedicine. 2020 Aug 15;26:100498. doi: 10.1016/j.eclinm.2020.100498. eCollection 2020 Sep.
Abstract
摘要
相似文献
1
Leverage of genetic variants proxying smoking intensity to explore the broad health consequences of smoking.
EClinicalMedicine. 2020 Aug 15;26:100498. doi: 10.1016/j.eclinm.2020.100498. eCollection 2020 Sep.
2
Mendelian randomization case-control PheWAS in UK Biobank shows evidence of causality for smoking intensity in 28 distinct clinical conditions.
EClinicalMedicine. 2020 Jul 31;26:100488. doi: 10.1016/j.eclinm.2020.100488. eCollection 2020 Sep.
3
Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and Alcohol Use.
Biol Psychiatry. 2019 Jun 1;85(11):946-955. doi: 10.1016/j.biopsych.2018.11.024. Epub 2018 Dec 6.
4
Genetic Pleiotropy between Nicotine Dependence and Respiratory Outcomes.
Sci Rep. 2017 Dec 4;7(1):16907. doi: 10.1038/s41598-017-16964-4.
5
Smoking, alcohol consumption, and 24 gastrointestinal diseases: Mendelian randomization analysis.
Elife. 2023 Feb 2;12:e84051. doi: 10.7554/eLife.84051.
6
Effects of Genetic Variants in the Nicotine Metabolism Pathway on Smoking Cessation.
Genet Res (Camb). 2022 Sep 28;2022:2917881. doi: 10.1155/2022/2917881. eCollection 2022.
7
Proxying economic activity with daytime satellite imagery: Filling data gaps across time and space.
PNAS Nexus. 2023 Mar 29;2(4):pgad099. doi: 10.1093/pnasnexus/pgad099. eCollection 2023 Apr.
8
Evaluation of the implementation of the Framework Convention on Tobacco Control (FCTC) in Colombia.
Health Policy Plan. 2022 Mar 4;37(3):349-358. doi: 10.1093/heapol/czab143.
9
Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensity.
Carcinogenesis. 2016 Mar;37(3):269-279. doi: 10.1093/carcin/bgw012. Epub 2016 Jan 27.
10
Nicotine dependence and genetic variation in the nicotinic receptors.
Drug Alcohol Depend. 2009 Oct 1;104 Suppl 1(Suppl 1):S64-9. doi: 10.1016/j.drugalcdep.2009.06.003. Epub 2009 Jul 10.
本文引用的文献
1
Mendelian randomization case-control PheWAS in UK Biobank shows evidence of causality for smoking intensity in 28 distinct clinical conditions.
EClinicalMedicine. 2020 Jul 31;26:100488. doi: 10.1016/j.eclinm.2020.100488. eCollection 2020 Sep.
2
Genetic predisposition to smoking in relation to 14 cardiovascular diseases.
Eur Heart J. 2020 Sep 14;41(35):3304-3310. doi: 10.1093/eurheartj/ehaa193.
3
How humans can contribute to Mendelian randomization analyses.
Int J Epidemiol. 2019 Jun 1;48(3):661-664. doi: 10.1093/ije/dyz152.
4
Associations of genetically determined iron status across the phenome: A mendelian randomization study.
PLoS Med. 2019 Jun 20;16(6):e1002833. doi: 10.1371/journal.pmed.1002833. eCollection 2019 Jun.
5
The UK Biobank resource with deep phenotyping and genomic data.
Nature. 2018 Oct;562(7726):203-209. doi: 10.1038/s41586-018-0579-z. Epub 2018 Oct 10.
6
Triangulation in aetiological epidemiology.
Int J Epidemiol. 2016 Dec 1;45(6):1866-1886. doi: 10.1093/ije/dyw314.
7
MR-PheWAS: hypothesis prioritization among potential causal effects of body mass index on many outcomes, using Mendelian randomization.
Sci Rep. 2015 Nov 16;5:16645. doi: 10.1038/srep16645.
8
Use of Mendelian randomisation to assess potential benefit of clinical intervention.
BMJ. 2012 Nov 6;345:e7325. doi: 10.1136/bmj.e7325.
9
PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations.
Bioinformatics. 2010 May 1;26(9):1205-10. doi: 10.1093/bioinformatics/btq126. Epub 2010 Mar 24.
10
'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?
Int J Epidemiol. 2003 Feb;32(1):1-22. doi: 10.1093/ije/dyg070.
Zotero 插件